Dual-leg rehabilitation exoskeleton ReWalk® 7

standing positiongaitlower limbs mobility

Overview
The ReWalk Personal Exoskeleton (ReWalk® 7) is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and ascend/descend stairs and curbs. The system delivers user-initiated mobility via a wearable brace, a computer-based control system and motion sensors and is intended for everyday use at home, at work and in the community.

Key Benefits & Features

• Crutch-mounted control: integrated controls on the crutch for user-initiated stand, walk, speed selection and stop.
• Stairs and curbs: capability to ascend and descend stairs and negotiate curbs to expand real-world mobility.
• Smart control: wrist smartwatch and MyReWalk mobile app for mode selection, goal setting and usage tracking.
• Therapist tools: handheld therapist device and clinician app for on-the-fly parameter adjustment during training.
• Two customizable walking speeds to support transitions between indoor and outdoor environments.
• Extended battery life and durable construction designed for daily use.
• Adjustable fit: configurable ankle joints and software settings to enable individualized gait patterns.
• Coverage note: assigned to the Medicare brace benefit category (effective Jan 1, 2024); coverage is determined where reasonable and necessary.

Proven Health Benefits
Clinical studies and user surveys report that regular exoskeleton-assisted walking programs for people with SCI can provide benefits including:

• Reduced spasticity
• Improved trunk control
• Improved bowel and bladder function
• Improved circulation and cardiovascular markers
• Improved pain management
• Enhanced mental health and quality of life

Product Resources & Support
Available resources include clinical references, indications and contraindications, FAQs on eligibility and reimbursement, system component descriptions (brace, control unit, sensors), training and certification programs, and guidance for intended use settings (home, community, rehabilitation institutions).

References (selected)

• Systematic reviews and clinical trials on powered exoskeleton-assisted walking in SCI populations.
• Randomized and observational studies on bowel function, body composition, cardiovascular outcomes and gait following exoskeleton training.
• Postmarket user surveys and experience reports summarizing user outcomes.

Technical specifications

• Model / Commercial name: ReWalk® 7 (personal exoskeleton)
• Function: powered hip and knee motion to enable standing, walking, turning, ascending/descending stairs and curbs
• Control methods: crutch-mounted controls, wrist (smartwatch) control, MyReWalk mobile app, therapist handheld device
• Walking speeds: two customizable speeds
• Fit & adjustment: adjustable ankle joints; configurable software settings for individual gait patterns
• Use environments: indoor and outdoor, level surfaces, mild slopes, stairs and curbs (use under supervision or per certification where required)
• Intended user levels (USA): enables ambulatory functions for individuals with SCI at levels T7–L5 in home/community with a specially certified companion; T4–T6 intended for use in rehabilitation institutions per training program
• Coverage: Assigned to Medicare brace benefit category (effective Jan 1, 2024); coverage determined per medical necessity
• Durability: engineered for daily use with extended battery life
• Clinical evidence: supported by systematic reviews, randomized and observational studies and user surveys